Their filing for FDA approval of CagriSema in early 2026 puts them on track for a potential approval decision by late 2026 or early 2027
Emerging Peptide Therapeutics and Future Directions Pipeline Developments The peptide therapeutics pipeline continues to expand, with numerous candidates in various stages of clinical development
Shop phc v tt thch Nam mua ti rocy.vn c xp hng 5 5 sao Shop lm vic kh chuyn nghip
Human CD8+ T cell cross-reactivity across influenza A, B and C viruses
In addition, we also observed lower expression of BAX and caspase 3 and higher expression of Bcl-2 in hyperplastic prostate tissues compared with normal prostate tissues, which showed that with the down-regulation of GPX3, the apoptosis level of hyperplastic prostate was inhibited at the tissue level
Tear fluid shows promise as a non-invasive source for AD biomarkers, offering novel disease insights, and potential utility for pre-screening prior to PET imaging